With so many moving parts in our synthetic biology investigation, a documentary seemed like an ideal choice to showcase what we have been doing over the summer and how this research will translate into an effect mechanism of change in the surrounding scientific community. Our documentary consists of several components, including (but not limited to) explaining diabetes, the types of diabetes, and the prevalence of diabetes in the US and globally; explaining the premises of synthetic biology, the iGEM Jamboree and spirit of competition, and our project; seeking advice of tenured professors to evaluate the legitimacy and validity of our research and its ability to partially combat diabetes; and investigating the process, primarily dictated by the FDA, of how to approve a product to be marketed to the public. This documentary saw the consultations of several highly regarded professors including Dr. Susanna Keller, Dr. Keith Kozminski, Dr. Anthony McCall, and Dr. Gil Siegel on various topics as stated previously. Furthermore, Dr. Owen Fields of the Pfizer pharmaceutical company and Dr. John Herr provided us with commentary on the processes behind traversing through FDA approval to market our probiotic to the diabetic and pre-diabetic public. We concluded the documentary with a brief, yet nonetheless accurate survey of FDA regulations of our would-be product/probiotic as well as any labeling and fast-tracking categories our product could fall under.